Free Trial

Hellenic Dynamics (HELD) Competitors

GBX 1.62
+0.10 (+6.56%)
(As of 05/24/2024 ET)

HELD vs. N4P, DEMG, GDR, VAL, IDHC, TRLS, NFX, OCTP, PYC, and FAB

Should you be buying Hellenic Dynamics stock or one of its competitors? The main competitors of Hellenic Dynamics include N4 Pharma (N4P), Deltex Medical Group (DEMG), genedrive (GDR), ValiRx (VAL), Integrated Diagnostics (IDHC), Trellus Health (TRLS), Nuformix (NFX), Oxford Cannabinoid Technologies (OCTP), Physiomics (PYC), and Fusion Antibodies (FAB). These companies are all part of the "medical" sector.

Hellenic Dynamics vs.

Hellenic Dynamics (LON:HELD) and N4 Pharma (LON:N4P) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings, risk and community ranking.

Hellenic Dynamics has higher earnings, but lower revenue than N4 Pharma.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hellenic DynamicsN/AN/AN/AN/AN/A
N4 Pharma£23.52K81.69-£1.27M-£0.01-71.50

In the previous week, Hellenic Dynamics and Hellenic Dynamics both had 1 articles in the media. Hellenic Dynamics' average media sentiment score of 0.63 beat N4 Pharma's score of 0.00 indicating that Hellenic Dynamics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hellenic Dynamics
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
N4 Pharma
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

N4 Pharma received 103 more outperform votes than Hellenic Dynamics when rated by MarketBeat users.

CompanyUnderperformOutperform
Hellenic DynamicsN/AN/A
N4 PharmaOutperform Votes
103
65.61%
Underperform Votes
54
34.39%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hellenic Dynamics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
N4 Pharma
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

0.1% of Hellenic Dynamics shares are held by institutional investors. 72.9% of Hellenic Dynamics shares are held by insiders. Comparatively, 22.3% of N4 Pharma shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Hellenic Dynamics' return on equity of 0.00% beat N4 Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Hellenic DynamicsN/A N/A N/A
N4 Pharma N/A -77.81%-51.74%

Summary

Hellenic Dynamics beats N4 Pharma on 5 of the 7 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HELD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HELD vs. The Competition

MetricHellenic DynamicsDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£2.32M£1.16B£5.14B£1.62B
Dividend YieldN/A3.08%2.78%6.36%
P/E RatioN/A509.06117.631,886.39
Price / SalesN/A10,368.972,481.88340,068.21
Price / CashN/A10.1736.0525.29
Price / BookN/A7.615.372.90
Net IncomeN/A£160.60M£106.43M£157.95M
7 Day Performance-8.45%-1.25%-1.27%3.84%
1 Month Performance-43.97%1.42%3.24%12.02%
1 Year PerformanceN/A33.89%5.11%22.28%

Hellenic Dynamics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
N4P
N4 Pharma
0 of 5 stars
GBX 0.75
-6.3%
N/A-60.3%£2.02M£23,524.00-75.005News Coverage
Gap Down
DEMG
Deltex Medical Group
0 of 5 stars
GBX 0.11
-0.9%
N/A-92.1%£2.17M£1.78M-5.7537Gap Down
GDR
genedrive
0 of 5 stars
GBX 1.84
+0.8%
N/A-89.2%£2.63M£49,000.00-36.8043News Coverage
VAL
ValiRx
0 of 5 stars
GBX 2
-9.1%
N/A-68.7%£2.65MN/A-66.678Gap Up
IDHC
Integrated Diagnostics
0 of 5 stars
GBX 0.32
+2.5%
N/A-32.4%£1.94M£4.12B16.156,692
TRLS
Trellus Health
0 of 5 stars
GBX 1.73
+4.5%
N/A-77.1%£2.79M£35,000.00-57.5031Gap Down
High Trading Volume
NFX
Nuformix
0 of 5 stars
GBX 0.20
+8.1%
N/A-20.8%£1.64M£50,000.00-1.633Gap Down
OCTP
Oxford Cannabinoid Technologies
0 of 5 stars
GBX 0.14
+2.1%
N/A-81.0%£1.56MN/A-53.107News Coverage
Gap Down
PYC
Physiomics
0 of 5 stars
GBX 1.12
-10.7%
N/A-42.0%£1.51M£900,707.00-13.8310Gap Up
FAB
Fusion Antibodies
0 of 5 stars
GBX 3.47
+2.1%
N/A-45.7%£3.31M£1.58M-38.5648Gap Up

Related Companies and Tools

This page (LON:HELD) was last updated on 5/25/2024 by MarketBeat.com Staff

From Our Partners